How should methotrexate be administered with folic acid in an adult with rheumatoid arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Administer Methotrexate with Folic Acid in Rheumatoid Arthritis

All patients with rheumatoid arthritis taking methotrexate must receive at least 5 mg of folic acid weekly, administered on all days except the day(s) methotrexate is taken, to reduce gastrointestinal and hepatic toxicity without compromising therapeutic efficacy. 1, 2

Standard Dosing Protocol

Methotrexate Administration

  • Administer methotrexate once weekly only—never daily—as daily dosing causes significantly more liver enzyme elevations and reduced efficacy 3
  • The typical starting dose ranges from 7.5-15 mg weekly, taken as a single dose or divided over 24 hours on one day per week 1

Folic Acid Supplementation Regimen

  • Prescribe folic acid at a minimum of 5 mg weekly for all patients on methotrexate 1, 2
  • The most practical dosing schedule is 1 mg folic acid daily (providing 7 mg/week total), skipping only the day methotrexate is taken 1, 2
  • Alternative acceptable regimen: 5 mg folic acid once weekly, given 24 hours after the methotrexate dose 4
  • For patients on higher methotrexate doses (>15 mg/week), consider increasing folic acid to 7-10 mg weekly 1, 2

Rationale for Timing

The critical rule is to avoid giving folic acid on the same day as methotrexate because folic acid may theoretically compete for cellular uptake of methotrexate, potentially reducing its therapeutic effect. 1

  • This timing recommendation is based on the mechanism that both compounds compete for the same cellular transport systems 1
  • Studies confirm that folic acid supplementation at ≤5 mg/week does not reduce methotrexate efficacy when properly timed 1, 5

Evidence for Toxicity Reduction

Gastrointestinal Protection

  • Folic acid reduces GI side effects (nausea, vomiting, abdominal pain) by 26% relative risk (9% absolute risk reduction) 5
  • This protection occurs without compromising disease control as measured by joint counts and disease activity scores 5, 6

Hepatic Protection

  • Folic acid supplementation reduces abnormal liver enzyme elevation by 77% relative risk (16% absolute risk reduction) 5
  • Daily 1 mg folic acid provides significant hepatoprotection regardless of methotrexate dose 2

Treatment Continuation

  • Folic acid reduces patient withdrawal from methotrexate for any reason by 61% relative risk (15% absolute risk reduction) 5
  • Continuation rates at 1-4 years reach 74-87% with folic acid supplementation, at the upper end of reported ranges 7

Important Clinical Caveats

What NOT to Do

  • Never use folinic acid (leucovorin) for routine supplementation—it is more expensive and doses >5 mg/week may paradoxically reduce methotrexate efficacy (increasing tender and swollen joints) 1, 2
  • Never prescribe less than 5 mg folic acid weekly—lower doses have insufficient evidence for toxicity reduction 2
  • Never give folic acid on the same day as methotrexate—this may interfere with therapeutic efficacy 1

When to Increase Folic Acid Dose

  • Consider increasing above 5 mg/week (up to 10-30 mg/week) if persistent GI symptoms occur despite adequate methotrexate dosing 2
  • Patients on methotrexate 20-30 mg/week may benefit from proportionally higher folate supplementation 2

Monitoring Requirements

Despite folic acid supplementation, regular monitoring remains mandatory:

  • First 3 months: Complete blood count, liver function tests, and creatinine at least monthly 3
  • After stabilization: Complete blood count and liver function tests every 3-6 months 3
  • Lack of folate supplementation is a major risk factor for hematologic toxicity, making adherence critical 1, 3

Managing Persistent Side Effects

If GI intolerance persists despite folic acid:

  • Split the weekly methotrexate dose into 2-3 administrations over 24 hours (still only one day per week) 3
  • Administer methotrexate with food or at bedtime 3
  • Consider switching from oral to subcutaneous/intramuscular methotrexate 3
  • Increase folic acid dose to 7-10 mg weekly 2

Common Pitfall to Avoid

Do not confuse routine folic acid supplementation (for prevention) with leucovorin rescue therapy (for methotrexate overdose or severe toxicity)—leucovorin is the antidote for acute toxicity and must be given immediately in overdose situations, regardless of timing concerns. 1, 3

References

Guideline

Methotrexate and Folic Acid Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Folic Acid Dosing with Methotrexate for Rheumatoid Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Methotrexate Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the role of folinic acid (leucovorin) in patients with rheumatoid arthritis taking methotrexate?
How do you adjust the dose of methotrexate (disease-modifying antirheumatic drug) in relation to folic acid supplementation for an adult patient with seronegative arthritis?
What is the recommended folic acid supplementation regimen for an adult patient with seronegative arthritis taking methotrexate?
Can I take folic acid with methotrexate (MTX) 7.5mg and what is the recommended dose?
Why are methotrexate (MTX) and folic acid given alternately in the treatment of Rheumatoid Arthritis (RA)?
Is off‑label methylene blue appropriate for cognitive (brain) enhancement, and what dosing regimen and safety precautions (including G6PD deficiency, serotonergic drug interactions, pregnancy, anemia, and renal or hepatic impairment) should be considered?
A woman with ferritin 300 ng/mL and vitamin B12 172 pg/mL has intermittent diffuse hair shedding for two years; what is the likely cause and how should it be managed?
What is the recommended treatment approach for a 57‑year‑old woman with myeloperoxidase anti‑neutrophil cytoplasmic antibody‑positive systemic vasculitis?
What is the appropriate diagnostic workup for a patient suspected of myeloperoxidase (MPO) anti‑neutrophil cytoplasmic antibody (ANCA)‑associated systemic vasculitis?
What are the causes of hepatorenal syndrome?
In a non‑pregnant woman of reproductive age with hyperthyroidism who is not trying to conceive, are carbimazole and methimazole interchangeable and what is the recommended starting dose?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.